MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0003999
Innosurge Medicaments Private Limited
Innosurge Medicaments Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹21.39 Lakh
▼ 54% YoY
Net profit · FY 2025
₹1.67 Lakh
Net margin 7.8%
EBITDA · FY 2025
₹1.72 Lakh
EBITDA margin 8%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5.12 Lakh
Issued & subscribed
Company age
30 yrs
Est. 1996
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Innosurge Medicaments Private Limited
Data last updated:
Innosurge Medicaments Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 20 February 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33112DL1996PTC076490. Its GSTIN is 07AABCI9205R1Z3 (Delhi).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5.12 Lakh. It is led by directors Prteek Mathur and Rajni Mathur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pocket A – 12 Flat No 8 A Vaishali Apartments Kalkaji Extension, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.39 Lakh, a decline of 54% compared to the previous year. For the same year it recorded a net profit of ₹1.67 Lakh (net margin 7.8%) and EBITDA of ₹1.72 Lakh (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 4% over five years.
Innosurge Medicaments Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0003999). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U33112DL1996PTC076490
Registration Number 076490
Incorporation Date 20 February 1996
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0003999
Key People
Prteek Mathur Director Rajni Mathur Director Recognitions & Rankings of Innosurge Medicaments
Contact details
Innosurge Medicaments Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressPocket A – 12 Flat No 8 A Vaishali Apartments Kalkaji Extension, New Delhi, Delhi, India – 110019
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Innosurge Medicaments Private Limited, buy the company report.
Comprehensive company report
Innosurge Medicaments Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Innosurge Medicaments is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Innosurge Medicaments Private Limited, buy the company report.
Financials of Innosurge Medicaments Private Limited
FY 2025 filings availableInnosurge Medicaments Private Limited reported revenue of ₹21.39 Lakh (down 54% YoY) for FY 2025.
Revenue · FY 2025
₹21.39 Lakh ▼ 54%
Net profit · FY 2025
₹1.67 Lakh margin 7.8%
EBITDA · FY 2025
₹1.72 Lakh margin 8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 54%
3 years · compounded
▲ 3%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 85%
3 years · compounded
▲ 61%
5 years · compounded
▲ 7%
Revenue fell 54% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 85% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.72 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8% | ||||
| Net Profit Margin | 7.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innosurge Medicaments Private Limited, buy the company report.
Board of directors of Innosurge Medicaments Private Limited
Innosurge Medicaments has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prteek Mathur | Director | 20 May 2010 | 16 Years 5 Months | Current |
| Rajni Mathur Also directs: Myovatec Surgical Systems Pvt Ltd | Director | 20 Feb 1996 | 30 Years 8 Months | Current |
Auditor
Innosurge Medicaments Private Limited is audited by SALARPURIA & PARTNERS for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SALARPURIA & PARTNERS | FY 2020 | 302113E |
Shareholding
The shareholding of Innosurge Medicaments Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Innosurge Medicaments Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Innosurge Medicaments Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innosurge Medicaments Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Innosurge Medicaments has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCI9205R1Z3 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Innosurge Medicaments Private Limited, buy the company report.
Recent activity
Innosurge Medicaments Private Limited has 3 board changes on record since 1996: 2 appointments and 1 cessation. The latest: Adesh Dayal Mathur ceased to be Director on 04 Jun 2011.
AGM
Innosurge Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Innosurge Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Adesh Dayal Mathur ceased to be Director.
Appointed
Prteek Mathur was appointed as Director.
Appointed
Rajni Mathur was appointed as Director.
Incorporation
20 Feb 1996
Innosurge Medicaments Private Limited was registered on 20 Feb 1996 with Roc Delhi & aged 30 years 8 months as per MCA records.
Frequently asked questions
Innosurge Medicaments is an active private limited company based in New Delhi, Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 20 February 1996 (30+ years old) and is registered under CIN U33112DL1996PTC076490.
Innosurge Medicaments has 2 current directors:
- Prteek Mathur - Director
- Rajni Mathur - Director
The latest financial statements of Innosurge Medicaments on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Innosurge Medicaments is 07AABCI9205R1Z3, registered in Delhi.
The CIN (Corporate Identification Number) of Innosurge Medicaments is U33112DL1996PTC076490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innosurge Medicaments was incorporated on 20 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Delhi.
Adesh Dayal Mathur ceased to be Director on 04 Jun 2011. Prteek Mathur was appointed as Director on 20 May 2010. Rajni Mathur was appointed as Director on 20 Feb 1996.
Yes, Innosurge Medicaments is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0003999).
The registered office of Innosurge Medicaments is at Pocket A – 12 Flat No 8 A Vaishali Apartments Kalkaji Extension, New Delhi, Delhi, India – 110019.
Innosurge Medicaments operates in the healthcare industry, in the medical and laboratory equipment segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages